Diagnostic biopsy of sentinel lymph nodes in mammary gland cancer

Author:

Nikitenko R. P.ORCID,Koichev E. A.ORCID,Degtyarenko S. P.ORCID

Abstract

Objective.To improve the diagnostic biopsy of sentinel lymph nodes in patients, suffering mammary gland cancer, using fluorescent lymphography, and to reduce the quantity of postoperative complications. Materials and methods. In 2016 – 2021yrs period on the base of Odessa Regional Clinical Hospital 400 patients, suffering mammary gland cancer Stages Т1–Т3N0М0, were operated on with application of fluorescent lymphography, using two dyers – the patent blue and indocyanine green. All the patients were distributed into two groups. In Group I (a control one) in 200 patients the sentinel lymph nodes biopsy was performed. The dyer patent blue was applied for the lymph nodes coloring.In Group II (the main) in 200 women–patients the sentinel lymph nodes biopsy, using the patent blue and fluorescent dyer indocyanine green, was performed. Both dyers were injected subdermally along the external areolar edge in the dose 2 ml of the dyer solution. Results. Total 5–year survival after axillary lymphodissection and after the sentinel lymph node biopsy have constituted 91and 92%, accordingly, while the recurrence–free 5–year survival – 82.2 and 83.9%, accordingly. Regional recurrence in sentinel lymph nodes on the affected mammary gland side was diagnosed in 1.1% of the women–patients. In 58% of the women–patients the sentinel lymph nodes were clear, and that’s why a subsequent lymphodissection was not indicated to perform. Metastatic lymph nodes were revealed in 42% of the women–patients. Conclusion. The method of diagnostic biopsy of sentinel lymph nodes in patients, suffering mammary gland cancer, using dyers, permits in majority of them to abandon traumatic operations in favor of organ–preserving interventions, thus reducing the postoperative complications rate significantly.

Publisher

Liga-Inform, Ltd.

Subject

General Medicine

Reference20 articles.

1. Canavese G, Bruzzi P, Catturich A, Tomei D, Carli F, Garrone E, et al. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node–Negative Early–Stage Breast Cancer: 15–Year Follow–Up Update of a Randomized Clinical Trial. Ann Surg Oncol. 2016 Aug;23(8):2494–500. doi: 10.1245/s10434–016–5177–4. Epub 2016 Mar 14. PMID: 26975739.

2. Van Seijen M, Lips EH, Thompson AM, Nik–Zainal S, Futreal A, Hwang ES, et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019 Aug;121(4):285–92. doi: 10.1038/s41416–019–0478–6. Epub 2019 Jul 9. PMID: 31285590; PMCID: PMC6697179.

3. Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Arch Pathol Lab Med. 2018 Nov;142(11):1364–82. doi: 10.5858/arpa.2018–0902–SA. Epub 2018 May 30. PMID: 29846104.

4. Zhang G, Li C, Tian G, Cheng X, Li Y, Ma L. Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis. Medicine (Baltimore). 2020 Dec 24;99(52):e23593. doi: 10.1097/MD.0000000000023593. PMID: 33350734; PMCID: PMC7769333.

5. Jo MJ, Park JY, Song JS, Kook MC, Ryu KW, Cho SJ, et al. Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer. World J Gastroenterol. 2015 Jan 14;21(2):667–74. doi: 10.3748/wjg.v21.i2.667. PMID: 25593497; PMCID: PMC4292303.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3